Summit Therapeutics (SMMT) Assets (2016 - 2025)
Historic Assets for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to $261.7 million.
- Summit Therapeutics' Assets fell 4795.11% to $261.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $261.7 million, marking a year-over-year decrease of 4795.11%. This contributed to the annual value of $435.6 million for FY2024, which is 11461.55% up from last year.
- According to the latest figures from Q3 2025, Summit Therapeutics' Assets is $261.7 million, which was down 4795.11% from $324.0 million recorded in Q2 2025.
- Over the past 5 years, Summit Therapeutics' Assets peaked at $664.2 million during Q4 2022, and registered a low of $95.7 million during Q2 2022.
- In the last 5 years, Summit Therapeutics' Assets had a median value of $218.5 million in 2023 and averaged $257.9 million.
- As far as peak fluctuations go, Summit Therapeutics' Assets skyrocketed by 48582.04% in 2022, and later crashed by 6944.31% in 2023.
- Over the past 5 years, Summit Therapeutics' Assets (Quarter) stood at $113.4 million in 2021, then soared by 485.82% to $664.2 million in 2022, then crashed by 69.44% to $202.9 million in 2023, then soared by 114.62% to $435.6 million in 2024, then plummeted by 39.91% to $261.7 million in 2025.
- Its last three reported values are $261.7 million in Q3 2025, $324.0 million for Q2 2025, and $383.8 million during Q1 2025.